Citeline Podcasts

HPV vaccines have come a long way since they were first introduced in 2006, though not without their share of bumps and misinformation campaigns. Dr Kenneth Alexander, chief, Division of Infectious Diseases and Vice-Chair for Research at Nemours Children’s Hospital-Florida, talks to Scrip about various facets along this journey and more including how data has evolved, why the US may not be the best example to emulate for HPV vaccination, low adolescent immunization rates, steeling to deal with misinformation from anti-vaxxers and new vaccines on the horizon.

https://scrip.pharmaintelligence.informa.com/SC148251/HPV-Vaccines--The-Journey-So-Far-And-Long-Road-Ahead

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。

今回取り上げた記事はこちら（複数）

「FDA's Woodcock To Supreme Court: Mifepristone Ruling Will Create 'Significant Chaos’（邦題意訳：FDA幹部、最高裁のミフェプリストン審議で「深刻な混乱」を危惧）」

https://pink.pharmaintelligence.informa.com/PS148056/FDAs-Woodcock-To-Supreme-Court-Mifepristone-Ruling-Will-Create-Significant-Chaos

「Fifth Circuit Mifepristone Ruling May Temporarily Halt Pharmacy Dispensing, Generic Approval（邦題意訳：ミフェプリストン控訴審判決、薬局販売とジェネリック承認は一時停止か）」

https://pink.pharmaintelligence.informa.com/PS148051/Fifth-Circuit-Mifepristone-Ruling-May-Temporarily-Halt-Pharmacy-Dispensing-Generic-Approval

「Will Mifepristone Be Recalled If Texas Ruling Remains In Effect? Biopharma Leaders Back FDA（邦題意訳：テキサス判決、有効ならミフェプリストンはリコール必至？　バイオ製薬社長らがFDA擁護）」

https://pink.pharmaintelligence.informa.com/PS148030/Will-Mifepristone-Be-Recalled-If-Texas-Ruling-Remains-In-Effect-Biopharma-Leaders-Back-FDA

世界の薬事規制ニュースPink Sheet（ピンクシート）とは？

https://www.citeline.com/ja-jp/products-services/regulatory-and-compliance/pink-sheet

Brian Yang and Dexter discuss Chinese biotech going overseas, new personal data overseas transfer standard contract, post-COVID vaccine development and CDE’s new trends.

Quick Listen: Scrip's Five Must-Know Things

https://scrip.pharmaintelligence.informa.com/SC148184/Quick-Listen-Scrips-Five-MustKnow-Things

Rob Krummen, the CEO of Vektor Medical, talked to Medtech Insight about Vektor’s vMap computational modeling system that relies on 12-lead electrocardiography data to identify unstable cardiac rhythms.

Further Reading

For more information on leadless Vektor Medical, atrial fibrillation and ECG technologies addressed in this interview, check out these articles from Medtech Insight.

Hyfe Hopes To Unlock Utility Of Monitoring Coughs

Cardio Catch-Up: Updates From B-Secur, egnite, Vektor, And Other Under-The-Radar Companies

Apple Vs. AliveCor: ECG Patent Battle Headed To Import Ban Decision

AliveCor’s Smartphone-Linked ECG First Product Assessed Under UK’s Rapid HTA Pilot

FDA Clears Eko’s Smart Stethoscope To Detect Heart Murmurs

CMS Proposes National Payments For Long-Term Continuous Electrocardiogram Monitoring

Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future

Further Listening:

Our other podcasts are available on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn- also now on Spotify Podcasts- and via smart speakers if one of these platforms has been set up as your default podcast provider.

The 31st annual Pharma R&D Review.

The 31st annual Pharma R&D Review.

The 31st annual Pharma R&D Review.

The 31st annual Pharma R&D Review.

The 31st annual Pharma R&D Review.